Tau proteins are a family of proteins that are encoded by the MAPT gene containing three to four proteins. Tau proteins play essential roles in neuronal signaling, cell adhesion, and cytoskeletal stabilization. The abnormal aggregation of Tau proteins are observed in a variety of neurological diseases, including Alzheimer's disease, frontotemporal dementias, and Pick's disease. This abnormal aggregation is known as Neurofibrillary tangle (NFT) formation. NFT's are affected by various mutations in the MAPT gene, which lead to excessive formation of aggregates. Tau proteins have a range of functions within the body. Tau proteins are important signaling molecules in the central nervous system. They are involved in processes such as presynaptic vesicle trafficking, axonal outgrowth, branching, and neuronal cell adhesion. They are also involved in the maintenance of structural integrity as part of the mitotic apparatus. Tau proteins stabilize microtubules that are responsible for neuronal transport processes and key for growth and development of neuronal cells. On the other hand, tau proteins can be toxic when they are abnormally hyperphosphorylated. Hyperphosphorylated tau proteins are seen in a variety of neurological diseases, including Alzheimer’s disease. In Alzheimer’s disease, these hyperphosphorylated Tau proteins have a tendency to aggregate and form NFTs, which are believed to cause the cognitive and memory deficits seen in these diseases. Tau proteins are also associated with other diseases. Frontotemporal dementias are caused by mutations in the MAPT gene that leads to overexpression of abnormal Tau proteins. Tauopathies, a general term for diseases which are associated with Tau protein dysfunction, is seen in progressive supranuclear palsy, corticobasal degeneration, and Pick’s disease. These neurodegenerative diseases are characterized by Tau protein aggregation in neurons and other types of cells. In conclusion, Tau proteins are crucial for neuronal development, function, and stability. However, pathological Tau proteins are responsible for a range of neurological diseases, including Alzheimer’s, frontotemporal dementias, progressive supranuclear palsy, and Pick’s disease. Research into Tau protein structure and function as well as potential treatments are ongoing.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom